Home - IAVI

Translating scientific discoveries
into affordable, globally accessible
public health solutions
Translating scientific discoveries
into affordable, globally accessible
public health solutions
Translating scientific discoveries
into affordable, globally accessible
public health solutions
Translating scientific discoveries
into affordable, globally accessible
public health solutions
Translating scientific discoveries
into affordable, globally accessible
public health solutions
Translating scientific discoveries
into affordable, globally accessible
public health solutions

LATEST NEWS

Intranasal COVID-19 candidate

Preclinical results support intranasal delivery of IAVI’s COVID-19 vaccine candidate

Vaccine Literacy Library

IAVI launches toolkit to build vaccine literacy knowledge

IAVI C102 Liberia vaccine trial

First vaccinations in Phase I clinical trial of Lassa fever vaccine candidate

WHO - PPCs for mAbs for HIV prevention

Guide aims to ensure future HIV mAbs are affordable and globally accessible

Meet the IAVI scientist applying new tech to tackle HIV vaccine R&D

IAVI Report: Bali Pulendran on how adjuvants might improve mRNA vaccines

WHAT WE DO

What We Do

Discover

new approaches to developing vaccines and antibodies for HIV, TB, emerging infectious diseases, and neglected diseases.

Accelerate

translational and clinical research through our laboratories in the U.S., India, and the U.K.

Build Capacity

in-country for researching vaccine candidates while strengthening local public health and scientific expertise.

Partner

with industry and enlist biopharma product development skills to develop innovative products tailored to target populations.

Share

IAVI’s resources with other innovators to help the global health community as a whole succeed.

Extend

IAVI’s core capabilities to solving disease prevention and treatment challenges.

About

Our Work

Our Science

News & Resources

©2022 International AIDS Vaccine Initiative. International AIDS Vaccine Initiative^®, IAVI^®, and the IAVI logo^® are registered trademarks of the International AIDS Vaccine Initiative, Inc.